{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:53:26Z","timestamp":1791298406046,"version":"4.1.0"},"reference-count":24,"publisher":"CAIRN.INFO","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:p>Introduction\u00a0: Dans le cadre de l\u2019essai DeprescrIPP-DAM, des d\u00e9l\u00e9gu\u00e9s de l\u2019Assurance maladie (DAM) ont rendu visite \u00e0 des m\u00e9decins g\u00e9n\u00e9ralistes (MG) pour les sensibiliser \u00e0 la d\u00e9prescription des inhibiteurs de la pompe \u00e0 protons (IPP) et leur pr\u00e9senter des strat\u00e9gies pour s\u2019engager dans le processus de d\u00e9prescription. L\u2019objectif de cette \u00e9tude \u00e9tait d\u2019explorer les interactions et exp\u00e9riences des DAM lors de leurs interventions. M\u00e9thodes\u00a0: \u00c9tude qualitative fond\u00e9e sur des entretiens semi-structur\u00e9s avec 12 DAM volontaires, selon une approche de th\u00e9orisation ancr\u00e9e. R\u00e9sultats\u00a0: Les DAM ont la capacit\u00e9 \u00e0 s\u2019adapter entre les objectifs de contr\u00f4le m\u00e9dical et l\u2019accompagnement des professionnels de sant\u00e9. Ils s\u2019adaptent en utilisant leurs ressources internes et leur formation pour transmettre les messages aux MG, tout en maintenant une relation de confiance. Dans l\u2019essai DeprescrIPP-DAM, la formation innovante et la flexibilit\u00e9 de l\u2019intervention ont \u00e9t\u00e9 identifi\u00e9es comme les principaux facteurs d\u2019efficacit\u00e9. L\u2019identit\u00e9 professionnelle des DAM a pu constituer un obstacle dans le contexte de tensions entre les MG et l\u2019Assurance maladie nationale au moment de l\u2019essai. Les DAM ont identifi\u00e9 plusieurs freins \u00e0 la d\u00e9prescription, notamment le r\u00f4le des autres sp\u00e9cialit\u00e9s m\u00e9dicales, la charge de travail des MG, et la r\u00e9sistance des patients. Conclusion\u00a0: La simplification des supports de formation, l\u2019implication d\u2019autres sp\u00e9cialistes m\u00e9dicaux et la possibilit\u00e9 d\u2019audits et retours r\u00e9guliers de donn\u00e9es individualis\u00e9es aux MG pourraient \u00eatre b\u00e9n\u00e9fiques pour les futures interventions de d\u00e9prescription des IPP bas\u00e9es sur les DAM.<\/jats:p>","DOI":"10.3917\/spub.263.0087","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:32:30Z","timestamp":1791297150000},"page":"87-99","source":"Crossref","is-referenced-by-count":0,"title":["Visites des d\u00e9l\u00e9gu\u00e9s de l\u2019Assurance maladie aupr\u00e8s de m\u00e9decins\u00a0g\u00e9n\u00e9ralistes\u00a0: une \u00e9tude qualitative par entretiens semi-structur\u00e9s dans le cadre d\u2019un essai de d\u00e9prescription des\u00a0inhibiteurs de la pompe \u00e0 protons"],"prefix":"10.3917","volume":"vol. 38","author":[{"given":"Florian","family":"Hurteau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Paneccasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Nguyen-Soenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pascal","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2273","reference":[{"key":"rb1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02810-1"},{"key":"rb2","unstructured":"2. Haute Autorit\u00e9 de sant\u00e9 (HAS). Fiche BUM - Bon usage des inhibiteurs de la pompe \u00e0 protons (IPP) [en ligne]. 2022 [visit\u00e9 le 02\/01\/2025]. Disponible sur : https:\/\/www.has-sante.fr\/jcms\/p_3372966\/fr\/fiche-bon-usage-des-inhibiteurs-de-la-pompe-a-protons-ipp."},{"key":"rb3","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12732"},{"key":"rb4","doi-asserted-by":"publisher","DOI":"10.1017\/S1463423623000026"},{"key":"rb5","unstructured":"5. L\u2019Assurance maladie. D\u00e9l\u00e9gu\u00e9 de l\u2019Assurance maladie [en ligne]. 2025 [Visit\u00e9 le 26\/03\/2025]. Disponible sur : https:\/\/www.assurance-maladie.ameli.fr\/carrieres\/metiers\/efficacite-systeme-sante\/delegue-assurance-maladie"},{"key":"rb6","doi-asserted-by":"publisher","DOI":"10.56746\/EXERCER.2024.204.254"},{"key":"rb7","unstructured":"7. Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, et al. D\u00e9prescrire les inhibiteurs de la pompe \u00e0 protons. Can Fam Physician. 2017 ; 63(5) : e253\u201365."},{"key":"rb8","doi-asserted-by":"publisher","DOI":"10.3917\/spub.226.0795"},{"key":"rb9","doi-asserted-by":"publisher","DOI":"10.2196\/60535"},{"key":"rb10","unstructured":"10. Corbin J, Strauss A. Basics of qualitative research : techniques and procedures for developing grounded theory. 4e \u00e9d. Los Angeles, London, New Delhi, Singapore, Washington DC, Boston : SAGE Publications, Inc ; 2014. 456 p."},{"key":"rb11","unstructured":"11. Glaser BG, Strauss AL. La d\u00e9couverte de la th\u00e9orie ancr\u00e9e : strat\u00e9gies pour la recherche qualitative. 2e \u00e9d. Malakoff : Armand Colin ; 2022. 416 p."},{"key":"rb12","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"rb13","unstructured":"13. Carzon M. Les assises du m\u00e9dicament. Note de synth\u00e8se Assurance Maladie. Information des professionnels de sant\u00e9 sur les produits de sant\u00e9 [en ligne]. 2011 [visit\u00e9 le 26\/03\/2025]. Disponible sur : https:\/\/sante.gouv.fr\/IMG\/pdf\/Michele_Carzon_-_CNAMTS_-_Information_des_professionnels_de_sante_sur_les_produits_de_sante-2.pdf"},{"key":"rb14","unstructured":"14. Dillot E. Promotion de l\u2019activit\u00e9 physique aupr\u00e8s des m\u00e9decins g\u00e9n\u00e9ralistes de Loire-Atlantique par les d\u00e9l\u00e9gu\u00e9s de l\u2019assurance maladie. [en ligne]. Nantes: Nantes Universitr\u00e9. 2023 [cit\u00e9 6 mai 2025]. Disponible sur : https:\/\/www.sudoc.fr\/25613989X"},{"key":"rb15","unstructured":"15. Paesbrugghe X, Legrand \u00c9. Visite des d\u00e9l\u00e9gu\u00e9s de l\u2019assurance maladie : ressenti des m\u00e9decins g\u00e9n\u00e9ralistes des Hauts de France [en ligne]. Lille : Universit\u00e9 de Lille ; 2019 [visit\u00e9 le 26\/03\/2025]. Disponible sur : https:\/\/www.sudoc.fr\/25613989X."},{"key":"rb16","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-020-01227-5"},{"key":"rb17","unstructured":"17. Buval \u00c9. \u00c9valuation des freins \u00e0 la d\u00e9prescription des inhibiteurs de la pompe \u00e0 protons en m\u00e9decine g\u00e9n\u00e9rale [en ligne]. Paris : Universit\u00e9 Paris Cit\u00e9 ; 2022. Disponible sur : https:\/\/dumas.ccsd.cnrs.fr\/dumas-03769071v1"},{"key":"rb18","unstructured":"18. Veyret JB. Freins \u00e0 la d\u00e9prescription des inhibiteurs de la pompe \u00e0 protons en m\u00e9decine g\u00e9n\u00e9rale : r\u00e9flexion bas\u00e9e sur une \u00e9tude qualitative men\u00e9e aupr\u00e8s de m\u00e9decins g\u00e9n\u00e9ralistes pratiquant en Belgique. UCLouvain ; 2023."},{"key":"rb19","unstructured":"19. Balint M. Le m\u00e9decin, son malade et la maladie. Payot : Paris ; 419 p."},{"key":"rb20","doi-asserted-by":"crossref","unstructured":"20. Farrell B, Thompson W, Black CD, Archibald D, Raman-Wilms L, Grassau P, et al. Health care providers\u2019 roles and responsibilities in management of polypharmacy : results of a modified Delphi. Can Pharm J (Ott). 1 2018 ; 151(6) : 395\u2013407.","DOI":"10.1177\/1715163518804276"},{"key":"rb21","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-019-0904-4"},{"key":"rb22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003983"},{"key":"rb23","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.60.2.307"},{"key":"rb24","unstructured":"24. Cordel F. Chapitre 7. Les limites du processus de gestion des risques. In : Gestion des risques et contr\u00f4le interne. De la conformit\u00e9 \u00e0 l\u2019analyse d\u00e9cisionnelle. Vuibert. 2019. pp. 203\u201332."}],"container-title":["Sant\u00e9 Publique"],"original-title":[],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:32:34Z","timestamp":1791297154000},"score":1,"resource":{"primary":{"URL":"https:\/\/stm.cairn.info\/revue-sante-publique-2026-3-page-87?lang=fr&ref=doi"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.3917\/spub.263.0087","relation":{},"ISSN":["0995-3914"],"issn-type":[{"value":"0995-3914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,5]]}}}